Wu W - Search Results

1

FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling.

Wang Y, Wahafu A, Wu W, Xiang J, Huo L, Ma X, Wang N, Liu H, Bai X, Xu D, Xie W, Wang M, Wang J. Wang Y, et al. Among authors: wu w. J Cell Mol Med. 2021 May;25(9):4487-4500. doi: 10.1111/jcmm.16536. Epub 2021 Apr 9. J Cell Mol Med. 2021. PMID: 33837625 Free PMC article.

2

Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.

Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J. Yu X, et al. Among authors: wu w. Life Sci. 2019 Nov 1;236:116917. doi: 10.1016/j.lfs.2019.116917. Epub 2019 Oct 12. Life Sci. 2019. PMID: 31614149 Free article.

3

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.

Alafate W, Xu D, Wu W, Xiang J, Ma X, Xie W, Bai X, Wang M, Wang J. Alafate W, et al. Among authors: wu w. J Exp Clin Cancer Res. 2020 Nov 11;39(1):239. doi: 10.1186/s13046-020-01750-4. J Exp Clin Cancer Res. 2020. PMID: 33176854 Free PMC article.

4

NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway.

Xiang J, Alafate W, Wu W, Wang Y, Li X, Xie W, Bai X, Li R, Wang M, Wang J. Xiang J, et al. Among authors: wu w. Cell Death Dis. 2022 Jan 14;13(1):58. doi: 10.1038/s41419-022-04512-6. Cell Death Dis. 2022. PMID: 35031599 Free PMC article.

5

CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.

Wang Y, Bao G, Zhang M, Xiang J, Zhou H, Wahafu A, Wu W, Ma X, Huo L, Bai X, Xie W, Liu P, Wang M. Wang Y, et al. Among authors: wu w. Exp Cell Res. 2022 May 1;414(1):113077. doi: 10.1016/j.yexcr.2022.113077. Epub 2022 Feb 25. Exp Cell Res. 2022. PMID: 35219647

6

A novel DNA damage and repair-related gene signature to improve predictive capacity of overall survival for patients with gliomas.

Li X, Wang Y, Wu W, Xiang J, Wang M, Yu H. Li X, et al. Among authors: wu w. J Cell Mol Med. 2022 Jul;26(13):3736-3750. doi: 10.1111/jcmm.17406. Epub 2022 May 26. J Cell Mol Med. 2022. PMID: 35615996 Free PMC article.

7

Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.

Alafate W, Li X, Zuo J, Zhang H, Xiang J, Wu W, Xie W, Bai X, Wang M, Wang J. Alafate W, et al. Among authors: wu w. CNS Neurosci Ther. 2020 Apr;26(4):475-485. doi: 10.1111/cns.13297. CNS Neurosci Ther. 2020. PMID: 32187449 Free PMC article.

8

Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients.

Wu W, Deng Z, Alafate W, Wang Y, Xiang J, Zhu L, Li B, Wang M, Wang J. Wu W, et al. Front Oncol. 2020 Oct 21;10:1750. doi: 10.3389/fonc.2020.01750. eCollection 2020. Front Oncol. 2020. PMID: 33194573 Free PMC article.

9

A Novel Risk Score Model Based on Eleven Extracellular Matrix-Related Genes for Predicting Overall Survival of Glioma Patients.

Li X, Wang Y, Wu W, Xiang J, Qi L, Wang N, Wang M, Yu H. Li X, et al. Among authors: wu w. J Oncol. 2022 Apr 29;2022:4966820. doi: 10.1155/2022/4966820. eCollection 2022. J Oncol. 2022. PMID: 35528238 Free PMC article.

10

A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients.

Wu W, Wang Y, Xiang J, Li X, Wahafu A, Yu X, Bai X, Yan G, Wang C, Wang N, Du C, Xie W, Wang M, Wang J. Wu W, et al. Front Oncol. 2022 May 12;12:729002. doi: 10.3389/fonc.2022.729002. eCollection 2022. Front Oncol. 2022. PMID: 35646656 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,718 results

Search Page

Filters